Pulmonary delivery of nanostructured lipid carriers for effective repurposing of salinomycin as an antiviral agent
Data
2020-10Autor
Pindiprolu, Sai Kiran S.S.
Kumar, Chirravuri S.Phani
Kumar Golla, Venu Sampath
Likitha, P.
K, Shreyas Chandra
Esub Basha, S. K.
Ramachandra, R. K.
Metadata
Mostrar registro completo
Documentos PDF
Resumo em língua estrangeira
Coronavirus disease outbreak caused a severe public health burden all over the world. Salinomycin (SAL) is a broad-spectrum antibiotic that had drawn attention in selective targeting of cancer and viral infections. Recent drug screen identified SAL as a potent antiviral agent against SARS-CoV-2. In this hypothesis, we discuss the potential of pulmonary delivery of SAL using nanostructured lipid carriers (NLCs) against SARS-CoV-2.
Palabras clave
Salinomicina; EndocitosisLink para o recurso
https://www.sciencedirect.com/science/article/pii/S0306987720310689?via%3DihubCollections
Estadísticas Google Analytics
Comments
Respuesta Comentario Repositorio Expeditio
Gracias por tomarse el tiempo para darnos su opinión.